What you need to know about biosimilars

On May 27, British Columbia became the first province to expand the use of biosimilars/biogenerics. Find out what this means for the more than 800,000 people in BC living with arthritis. To read our frequently asked questions on biosimilars/biogenerics, please click...

Arthritis Research Canada opens fourth centre

Arthritis Research Canada, the largest clinical arthritis research institution in North America, continues to grow with its newest centre located at McGill University.   Drs. Deborah Da Costa, Michal Abrahamowicz, Susan Bartlett and Marie Hudson will join the new...

Arthritis Research Canada graced by talk of Olympic proportions

On June 28, Nancy Greene Raine, Canada’s Female Athlete of the 20th Century, joined staff and scientists as Arthritis Research Canada’s Distinguished Guest Speaker for the organization’s Annual Retreat. Greene Raine provided an inspirational presentation on her...

Living with arthritis? Learn about biosimilars

What is a biosimilar/biogeneric? Biologics are medicines taken by IV or self-injection and are made up of large protein molecules derived from living cells. There are now two versions of biologics: “originators” and “biosimilars” (also known as biogenerics). These are...